Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
City of Hope’s Mustafa Raoof: Medicare Advantage cancer patients more likely to die within 30 days after complex surgery
Conversation with The Cancer Letter

City of Hope’s Mustafa Raoof: Medicare Advantage cancer patients more likely to die within 30 days after complex surgery

Medicare Advantage, the private insurance alternative to traditional Medicare, is popular for several reasons: lower premiums, dental and vision coverage, and a cap on out-of-pocket costs.
January 20, 2023
Vol.49 No.03
By Matthew Bin Han Ong
In Brief

Ted Schwartz family gifts $15M to City of Hope to accelerate immunotherapy research

Ted Schwartz, a cancer survivor, gifted $15M to City of Hope that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the CAR T-cell therapy that saved his life. 
September 30, 2022
Vol.48 No.35
Leslie Bernstein, a brilliant scientist, a dedicated advocate, and a compassionate friend
FreeObituary

Leslie Bernstein, a brilliant scientist, a dedicated advocate, and a compassionate friend

The breast cancer community has lost a friend, a partner, and a dedicated patient advocate.
September 16, 2022
Vol.48 No.33
By Frances M. Visco
In Brief

Kevin Campbell named CIO of TGen

Kevin Campbell was named chief information officer of the Translational Genomics Research Institute, part of City of Hope.
September 16, 2022
Vol.48 No.33
In Brief

City of Hope receives $25M gift from Argyros family

City of Hope has received a $25 million gift from Julia and George Argyros, longtime City of Hope supporters. 
September 16, 2022
Vol.48 No.33
In Brief

Lynda Carter Altman establishes fund for City of Hope and TGen to support research in sAML diagnostics and treatment

Lynda Carter Altman and Robert AltmanThe Translational Genomics Research Institute, part of City of Hope, formed a partnership with actress, singer-songwriter, and advocate, Lynda Carter Altman, to accelerate diagnostics and treatments, including precision medicine approaches, for secondary acute myeloid leukemia.
September 16, 2022
Vol.48 No.33
Remembering legendary biostatistician Leslie Bernstein
FreeObituary

Remembering legendary biostatistician Leslie Bernstein

Leslie Bernstein, PhD, a trailblazing cancer epidemiologist, died July 28. She was 82. 
September 09, 2022
Vol.48 No.32
By City of Hope staff
FreeIn Brief

City of Hope receives $7M to study interventions for lung cancer in older adults

City of Hope received nearly $7 million from the Patient-Centered Outcomes Research Institute to study how physical activity affects older adults undergoing lung cancer surgery.
August 05, 2022
Vol.48 No.31
City of Hope opens ambulatory cancer center in Irvine as part of $1B expansion

City of Hope opens ambulatory cancer center in Irvine as part of $1B expansion

In the latest phase of its plan to invest over $1 billion in Orange County, City of Hope has opened a multi-specialty outpatient cancer center in the county and hired 29 physicians to practice there.
July 29, 2022
Vol.48 No.30
In Brief

Philip Okala named system president at City of Hope

Philip Okala was named system president at City of Hope. 
June 17, 2022
Vol.48 No.24

Posts navigation

Previous1…678Next

Trending Stories

  • An opportunity for Trump: Position U.S. cancer science to lead the world
  • NIH eliminates the NCI Board of Scientific Advisors
    Over its 28 year history, BSA shaped NCI-funded extramural science
  • In the Headlines: “There’s no one to stand up for NCI right now.”
  • The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
    In a time of uncertainty, “react to the knowns, not the fear”
  • Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
    To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges
  • Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
    NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account